HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2016, Vol 4, Issue 5

Abstract

Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. The A1C test is a blood test that provides information about a person’s average levels of blood glucose, also called blood sugar, over the past 3 months. The Aim is to study roll of HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. The Study consists of 120 type 2 DM patients of 40-70 year age group along with age and sex matched healthy control. Fasting Blood samples were collected from all participants for measurement of Lipid profile, Blood sugar (FBS) and HbA1c. In case group, the mean concentration of Fasting blood glucose(mg/dl), S.Cholestrol (mg/dl), S.Triglyceride (mg/dl), S.HDL(mg/dl) and HbA1c(%) is 138.5±5.2, 265±10.5, 210.9±5.2, 38.6±6.3 and 10.6±1.0. Respectively while in control group it is 85.6±6, 156.9±8.5, 119.5±7.3, 44.5±3.2 and 5.2±0.5 respectively. The HbA1C might be used as a reliable biomarker in the screening of dyslipidemia in diabetes type-2 patients because it showed positive correlation with TC, TG, VLDL, and LDL-C but negative correlation with HDL-C. Keywords: HbA1c, dyslipidemia Type 2 Diabetes mellitus

Authors and Affiliations

Dr Rajul Lodha, Dr Renuka Z Lal, Dr Shweta Biyani

Keywords

Related Articles

Assessment of Preoperative Depression, Anxiety and Stress for Patients Awaiting Surgery in a Tertiary Care Hospital

Abstract: The burden of emotional states such as anxiety, depression and stress in people undergoing surgery is undeniable. The excessive and continuous effects of those emotional states have negative impact on people’s...

The Demographic, Clinical and Laboratory Profile of Patients with Giant Cell Arteritis: Case Series

The aim of the study was to describe the demographic, clinical and laboratory profile of patients with giant cell arteritis in northeast of Iran. In a retrospective study we reviewed the records of all patients that sati...

An Interventional Study Showing Effect of Yoga on Serum Cortisol of Depression Patients Attending Psychiatric OPD, SMS Hospital, Jaipur

Depression is a major cause of morbidity worldwide. WHO ranked it fourth in a list of most urgent health problems of the world? Depression is twice as common in women as in men and is well known to be associated with hyp...

Vitamin Deficiency And Periodontal Disease – A Tie- in Relationship

Abstract: Periodontal disease is a multifactorial disease, the origin of which remains incomprehensible. Various researches have shown that many systemic diseases either cause or exaggerate the course of certain periodo...

Antibiotic Susceptibility Pattern of Pyogenic Infectious Diseases in a Teaching Hospital of Tripura

India has one of the highest burdens of bacterial diseases in the world and thus, antibiotics have a significant role in reducing mortality and morbidity in the country. Area specific studies are required in monitoring t...

Download PDF file
  • EP ID EP371045
  • DOI -
  • Views 61
  • Downloads 0

How To Cite

Dr Rajul Lodha, Dr Renuka Z Lal, Dr Shweta Biyani (2016). HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. Scholars Journal of Applied Medical Sciences, 4(5), 1600-1602. https://europub.co.uk/articles/-A-371045